- Author
-
F.M. Houttuijn Bloemendaal
- Title
- Macrophages as a therapeutic target in inflammatory bowel disease
- Subtitle
- Lessons learned from anti-TNF therapy
- Supervisors
-
G.R. van den Brink
G.R.A.M. D'Haens - Co-supervisors
-
M.E. Wildenberg
P.J. Koelink - Award date
- 3 July 2020
- Number of pages
- 145
- ISBN
- 9789402820386
- Document type
- PhD thesis
- Faculty
- Faculty of Medicine (AMC-UvA)
- Abstract
-
This thesis explores the need for Fc-FcγR interaction by anti-TNF antibodies to achieve therapeutic response in inflammatory bowel disease (IBD). Multiple anti-TNF agents have been evaluated for IBD, including IgG1 antibodies infliximab and adalimumab, pegylated Fab’ fragment certolizumab, IgG4 anti-TNF CDP571, soluble TNF receptor I onercept and TNF receptor II-Fc fusion protein etanercept. While these TNF blocking strategies established their value in several immune mediated diseases, only IgG1 monoclonal antibodies demonstrated induction of complete endoscopic remission in IBD. This suggests that additional features besides TNF neutralization are necessary for therapeutic efficacy and these clinical observations initiated a closer evaluation of the effector mechanism of anti-TNF by multiple groups. This thesis focusses on Fc-FcγR interaction and investigates macrophages as effector cells.
In conclusion, this thesis shows evidence that the effector mechanism of anti-TNF requires FcγR cross-linking on macrophages to establish repolarization of an inflammatory macrophage towards a regulatory phenotype. The importance of macrophages in IBD etiology and therapeutics, defines shifting inflammatory macrophages towards a regulatory state as a goal for future therapeutic strategies. - Persistent Identifier
- https://hdl.handle.net/11245.1/584f3676-6767-4abc-bb14-e43f11922c0c
- Downloads
-
Thesis (complete)
Front matter
Outline of the thesis
Chapter 1: General introduction
Chapter 2: Anti-tumor necrosis factor with a glyco-engineered Fc-region has increased efficacy in mice with colitis
Chapter 3: TNF-anti-TNF immune complexes inhibit IL-12/IL-23 secretion by inflammatory macrophages via an Fc-dependent mechanism
Chapter 4: Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling
Chapter 5: Macrophages in Crohn’s disease creeping fat are predominantly inflammatory and produce calprotectin
Chapter 6: Summary, discussion and future perspective
Nederlandse samenvatting voor niet-ingewijden; Contributing authors; Dankwoord
Stellingen
Disclaimer/Complaints regulations
If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library, or send a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.